169 related articles for article (PubMed ID: 23734033)
1. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.
Rabi DM; Padwal R; Tobe SW; Gilbert RE; Leiter LA; Quinn RR; Khan N; ;
CMAJ; 2013 Aug; 185(11):963-7. PubMed ID: 23734033
[No Abstract] [Full Text] [Related]
2. Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
Mancia G; Cannon CP; Tikkanen I; Zeller C; Ley L; Woerle HJ; Broedl UC; Johansen OE
Hypertension; 2016 Dec; 68(6):1355-1364. PubMed ID: 27977392
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertension in patients with type 2 diabetes: a review of the recent evidence.
Chowdhury TA; Kumar S; Barnett AH; Dodson PM
J Hum Hypertens; 1999 Dec; 13(12):803-11. PubMed ID: 10618668
[No Abstract] [Full Text] [Related]
4. Intensive Blood Pressure Control and Diabetes Mellitus-Related Limb Events in Patients With Type 2 Diabetes Mellitus: Reanalysis of ACCORD.
Tran K; Stedman M; Chang TI
J Am Heart Assoc; 2021 Aug; 10(15):e021407. PubMed ID: 34320842
[No Abstract] [Full Text] [Related]
5. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
[TBL] [Abstract][Full Text] [Related]
6. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in diabetes: a call to action.
Campbell NR; Leiter LA; Larochelle P; Tobe S; Chockalingam A; Ward R; Morris D; Tsuyuki R
Can J Cardiol; 2009 May; 25(5):299-302. PubMed ID: 19417860
[TBL] [Abstract][Full Text] [Related]
8. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
[TBL] [Abstract][Full Text] [Related]
9. [Hypertension among very elderly].
Strandberg T
Duodecim; 2005; 121(13):1421-6. PubMed ID: 16134715
[No Abstract] [Full Text] [Related]
10. Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
Xie XX; Liu P; Wan FY; Lin SG; Zhong WL; Yuan ZK; Zou JJ; Liu LB
Int J Cardiol; 2016 Apr; 208():141-6. PubMed ID: 26855067
[No Abstract] [Full Text] [Related]
11. Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure.
Tsujimoto T; Kajio H
Hypertension; 2019 Dec; 74(6):1541-1550. PubMed ID: 31679424
[TBL] [Abstract][Full Text] [Related]
12. Optimal therapy in hypertensive subjects with diabetes mellitus.
Reboldi G; Gentile G; Angeli F; Verdecchia P
Curr Atheroscler Rep; 2011 Apr; 13(2):176-85. PubMed ID: 21234720
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
Kengne AP; Czernichow S; Huxley R; Grobbee D; Woodward M; Neal B; Zoungas S; Cooper M; Glasziou P; Hamet P; Harrap SB; Mancia G; Poulter N; Williams B; Chalmers J;
Hypertension; 2009 Aug; 54(2):399-404. PubMed ID: 19470869
[TBL] [Abstract][Full Text] [Related]
14. Targeting nocturnal hypertension in type 2 diabetes mellitus.
Rossen NB; Knudsen ST; Fleischer J; Hvas AM; Ebbehøj E; Poulsen PL; Hansen KW
Hypertension; 2014 Nov; 64(5):1080-7. PubMed ID: 25259747
[TBL] [Abstract][Full Text] [Related]
15. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
Karpov RS; Koshel'skaia OA; Khoroshilova IV
Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
[TBL] [Abstract][Full Text] [Related]
16. Hypertension treatment: how important is consistency of effect?
Sica DA
Hypertension; 2007 Aug; 50(2):287-8. PubMed ID: 17606859
[No Abstract] [Full Text] [Related]
17. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
El Aassri H; El Mghari G; El Ansari N
Pan Afr Med J; 2014; 17():193. PubMed ID: 25396019
[TBL] [Abstract][Full Text] [Related]
18. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
19. [Intensive control of arterial pressure prevents renal impairement in patients with diabetes mellitus].
Makolkin VI
Kardiologiia; 2009; 49(2):91-5. PubMed ID: 19254227
[No Abstract] [Full Text] [Related]
20. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension.
Marcadenti A; Fuchs SC; Moreira LB; Wiehe M; Gus M; Fuchs FD
Am J Hypertens; 2011 Feb; 24(2):175-80. PubMed ID: 20885370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
